INV-451

N/A

Report date: 2025/06/11 10:27:38

Base Information

Drug NameINV-451

Drug Alias NameCAR T-cell therapy (invIOs/Medical University of Innsbruck)

ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy > Chimeric antigen receptor T cell therapy

Mechanisms of ActionImmunostimulantsT lymphocytes stimulants

TargetsUpdating

Therapy Area/IndicationsLung Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustria

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedizinische Universität Innsbruck, Austria

China Registration ClassN/A

Develop Information

Active CompaniesinvIOs GmbH Medizinische Universität Innsbruck, Austria

Inactive CompaniesN/A

Active IndicationsLung Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A